date,title,source
Oct-24-18,"Analysis: Positioning to Benefit within Spectrum Pharmaceuticals, Carnival, Cadence Design, Tandem Diabetes Care, Rigel Pharmaceuticals, and Regeneron Pharmaceuticals  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Oct-29-18,"Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE (fostamatinib disodium hexahydrate) in Japan and other Asian Countries",PR Newswire
Oct-30-18,Rigel Announces Conference Call and Webcast to Report Third Quarter 2018 Financial Results,PR Newswire
Nov-01-18,Rigel to Present Data on Fostamatinib in Three Presentations at the 60th American Society of Hematology Annual Meeting & Exposition,PR Newswire
Nov-06-18,"Rigel Pharmaceuticals (RIGL) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-06-18,Rigel: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Rigel Announces Third Quarter 2018 Financial Results and Provides Company Update,PR Newswire
Nov-19-18,Implied Volatility Surging for Rigel Pharmaceuticals (RIGL) Stock Options,Zacks
Nov-29-18,What does Rigel Pharmaceuticals Incs (NASDAQ:RIGL) Balance Sheet Tell Us About Its Future?,Simply Wall St.
